UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

Journal of endocrinological investigation, 2006-04, Vol.29 (4), p.298-302

2006

Volltextzugriff (PDF)

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Journal of clinical oncology, 2023-08, Vol.41 (23), p.3881-3890

2023

Volltextzugriff (PDF)

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

Journal of endocrinological investigation, 2006-04, Vol.29 (4), p.298

2006

Volltextzugriff (PDF)

Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease

Endocrine-related cancer, 2005-03, Vol.12 (1), p.109-117

2005

Volltextzugriff (PDF)

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

Annals of oncology, 2006-05, Vol.17 (suppl-5), p.v118-v122

2006

Volltextzugriff (PDF)

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010)

Journal of the National Cancer Institute. Monographs, 2011-10, Vol.2011 (43), p.147-151

2011

Volltextzugriff (PDF)

Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?

Annals of oncology, 2006-08, Vol.17 (8), p.1336-1337

2006

Volltextzugriff (PDF)

Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism

Annals of oncology, 2011-04, Vol.22 (4), p.988-990

2011

Volltextzugriff (PDF)

Intermediate Endpoints of Primary Systemic Therapy in Breast Cancer Patients

Journal of the National Cancer Institute. Monographs, 2011-10, Vol.2011 (43), p.142-146

2011

Volltextzugriff (PDF)

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease

Prostate cancer and prostatic diseases, 2009-03, Vol.12 (1), p.94-99

2009

Volltextzugriff (PDF)

Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen

Annals of oncology, 2009-12, Vol.20 (12), p.2019-2020

2009

Volltextzugriff (PDF)

The neuroendocrine phenotype in prostate cancer: basic and clinical aspects

Journal of endocrinological investigation, 2005, Vol.28 (11 Suppl International), p.141-145

2005

Volltextzugriff (PDF)

Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial

Endocrine-related cancer, 2005-06, Vol.12 (2), p.383-392

2005

Volltextzugriff (PDF)

Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma

Annals of oncology, 2009-02, Vol.20 (2), p.389-390

2009

Volltextzugriff (PDF)

Management of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevation

Annals of oncology, 2006-12, Vol.17 (12), p.1854-1855

2006

Volltextzugriff (PDF)

Management of neuroendocrine differentiated breast carcinoma

Breast (Edinburgh), 2004-12, Vol.13 (6), p.527-529

2004

Volltextzugriff (PDF)

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly

Endocrine-related cancer, 2008-12, Vol.15 (4), p.1043-1053

2008

Volltextzugriff (PDF)

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial

Endocrine-related cancer, 2005-09, Vol.12 (3), p.657-666

2005

Volltextzugriff (PDF)

Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane

Journal of endocrinological investigation, 2006-06, Vol.29 (6), p.560-562

2006

Volltextzugriff (PDF)

Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapy

Annals of oncology, 2003-10, Vol.14 (10), p.1589-1590

2003

Volltextzugriff (PDF)

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)

Journal of the National Cancer Institute. Monographs, 2015-05, Vol.2015 (51), p.90-96

2015

Volltextzugriff (PDF)

Changes in Bone Mineral Density, Lean Body Mass and Fat Content as Measured by Dual Energy X-Ray Absorptiometry in Patients With Prostate Cancer Without Apparent Bone Metastases Given Androgen Deprivation Therapy

The Journal of urology, 2002-06, Vol.167 (6), p.2361-2367

2002

Volltextzugriff (PDF)

Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease

European journal of cancer (1990), 1994, Vol.30 (14), p.2082-2084

1994

Volltextzugriff (PDF)

Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension

British journal of cancer, 1996-06, Vol.73 (12), p.1581-1587

1996

Volltextzugriff (PDF)

1 – 25 von 320

Suche als RSS-Feed

Aktive Filter

ThemaMedical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(243)
Mit Volltextzugriff
(209)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(161)
Science & Technology
(104)
Life Sciences & Biomedicine
(89)
Female
(86)
Male
(66)
Middle Aged
(58)
Adult
(44)
Aged
(41)
Oncology
(41)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(35)
Old Medline
(29)
Animals
(28)
Breast Neoplasms - Drug Therapy
(18)
Treatment Outcome
(18)
Rats
(14)
Antineoplastic Agents - Therapeutic Use
(13)
Endocrinology & Metabolism
(13)
Bone Neoplasms - Secondary
(12)
Adolescent
(11)
Aged, 80 And Over
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

Independent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010)

Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?

Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism

Intermediate Endpoints of Primary Systemic Therapy in Breast Cancer Patients

Prognostic significance of disordered calcium metabolism in hormone-refractory prostate cancer patients with metastatic bone disease

Why castration-resistant prostate cancer patients with neuroendocrine differentiation should be addressed to a cisplatin-based regimen

The neuroendocrine phenotype in prostate cancer: basic and clinical aspects

Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer receiving chemotherapy: a randomised, placebo-controlled, double-blind study

Cytotoxic and antiproliferative activity of the single agent epirubicin versus epirubicin plus tamoxifen as primary chemotherapy in human breast cancer: a single-institution phase III trial

Activity and safety of a prolonged daily schedule of zoledronic acid in a patient with bone metastases from urothelial carcinoma

Management of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevation

Management of neuroendocrine differentiated breast carcinoma

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly

Etoposide, doxorubicin and cisplatin plus mitotane in the treatment of advanced adrenocortical carcinoma: a large prospective phase II trial

Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane

Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapy

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)

Changes in Bone Mineral Density, Lean Body Mass and Fat Content as Measured by Dual Energy X-Ray Absorptiometry in Patients With Prostate Cancer Without Apparent Bone Metastases Given Androgen Deprivation Therapy

Prognostic value in predicting overall survival of two mucinous markers: CA 15-3 and CA 125 in breast cancer patients at first relapse of disease

Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension

Aktive Filter

Suchergebnisse filtern